14158 Results (Page 83 of 567)
All Market Research Reports
Australia MPS-III (Sanfilippo Syndrome) Drugs Market Analysis
Australia MPS-III (Sanfilippo Syndrome) drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for MPS-III (Sanfilippo Syndrome) drugs is growing rapidly as a result of increase in research and development activities, patient support and advocacy programmes, launch of new emerging therapies, increase in healthcare spending globally. Phoenix Nest Inc, Allievex Corp, Amicus Therapeutics Inc, ArmaGen Inc, Esteve Pharmaceuticals SA, JCR Pharmaceuticals Co Ltd, M6P Therapeutics, Orchard Therapeutics Plc, Seelos Therapeutics, Inc., and BioStrategies LC are top key players operating in global MPS-III (Sanfilippo Syndrome) drugs market.
Australia Mucopolysaccharidosis I (MPS-I) Drugs Market Analysis
Australia Mucopolysaccharidosis I (MPS-I) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Rising consumer awareness, new drug approvals, enticing reimbursement plans, an established healthcare system, and the presence of sizable market competitors all drive the market for treating Mucopolysaccharidosis I. Major global players in Mucopolysaccharidosis I (MPS-I) Drugs Market are Takeda Pharmaceutical Company Limited, BioMarin Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., Sarepta Drugs, Abeona Drugs, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva, GC Pharma, JCR Pharmaceuticals Co Ltd., RegenxBio Inc., Sangamo Drugs, Inc., Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd.
Europe Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the Europe Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Europe Patient Support Programs (PSP) Market, offering unmatched value, accuracy and expert insights.
APAC Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the APAC Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the APAC Healthcare Reimbursement Market, offering unmatched value, accuracy and expert insights.
Poland Bioinformatics Market Analysis
The Poland Bioinformatics market is projected to grow from $89.03 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be an as increasing prevalence of chronic disease, advances in technology, and the growing pharmaceutical industry. The market is segmented by technology and by application. Some of the major players include Ardigen (POL), genXone (POL), Ideas4biology (POL), Agilent Technologies, IBM Life Sciences, and Qiagen.
Australia Medical Devices Market Analysis
This report presents a strategic analysis of the Australia Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Australia Medical Devices Market, offering unmatched value, accuracy and expert insights.
India Cancer Pain Management Market Analysis
India's Cancer Pain Management market is projected to grow from $118.57 Mn in 2022 to $224.39 Mn by 2030, registering a CAGR of 8.3% during the forecast period of 2022 - 2030. The main factors driving the growth would be government initiatives, increasing private sector investment, rising incidence of cancer, and technological advances. The market is segmented by drug type and by disease. Some of the major players include Accord Healthcare (IND), Dr. Reddy’s (IND), Pfizer, Abbott, and Teva Pharmaceuticals.
Australia Charcot-Marie-Tooth Disease (CMT) Therapeutics Market Analysis
Australia Charcot-Marie-Tooth Disease (CMT) Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The majority of hereditary peripheral neuropathies are Charcot-Marie-Tooth (CMT) illness, commonly referred to as hereditary motor and sensory neuropathy (HMSN). Genes that support or generate proteins important in the construction and operation of the myelin sheath or the peripheral nerve axon are mutated, leading to CMT. An increase in genetic illnesses will result in more innovations being made in this area, which will enhance market growth because there are many genes that cause these problems. The above-mentioned forecast period will witness the emergence of the market for Charcot Marie-Tooth disease due to multiple prospects that will be heightened by the rising focus on targeted therapies and the favorable government regulations. Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp., Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc. are some of the major players in the Charcot Marie Tooth Disease Market.
Italy Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the Italy Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Italy Healthcare Reimbursement Market, offering unmatched value, accuracy, and expert insights.
UK Telemedicine Market Analysis
The UK telemedicine market size was valued at $1.58 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.25% from 2022 to 2030 and will reach $16.2 Bn in 2030. The market is driven by factors such as the increasing adoption of digital health solutions and the growing prevalence of chronic diseases. The market is segmented by Component Type, Application Type, Modality Type, and Delivery Mode Type. The major players in the UK telemedicine market are Babylon Health (UK), Medicspot (UK), Doctor Care Anywhere (UK), Push Doctor (UK), Live Doctor (UK), Doctor on Demand, and others.
UAE Physiotherapy Market Analysis
The UAE physiotherapy market size was valued at $266 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.85% from 2022 to 2030 and will reach $452 Mn in 2030. UAE physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions such as obesity and diabetes. The market is segmented by Product Type, Application Type, and End User. The major layers in the UAE physiotherapy market Medstar Medical Equipment, Gulf Medical Equipment, Euro Med, Mediplus and others.
UK Electronic Health Records Market Analysis
The UK electronic health record market size was valued at $736 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 2% from 2022 to 2030 and will reach $862 Mn in 2030. This growth can be attributed to Technological advancements in healthcare offering a promising future for enhancing healthcare delivery through electronic health records. The market is segmented by product type, application type, and end user. Some of the major players are Cerner Healthcare, InPS, System C & Graphnet Health, TPP, and others.
Spain Dental Care Market Analysis
Spain's dental care market size is at around $692.48 Mn in 2022 and is projected to reach $1,054.71 Mn in 2030, exhibiting a CAGR of 5.4% during the forecast period of 2022-30. Emerging as the most attractive market of dental care tourism in Europe Post-Brexit is stirred by the change in corporate lead ownership of dental practices by key players like Dentix, Clínicas, Dentales Sanitas, Clínicas Dentales Fidentia. This report by is segmented by treatment type, age group, clinical setup, and demography and provides in-depth insights for corporations to target their competitive position in Spain’s dental services market.
China Nutritional Supplements Market Analysis
By 2030, it is anticipated that the China nutrition and supplements market will reach a value of $65.74 Bn from $30.67 Bn in 2022, growing at a CAGR of 10% during 2022-2030. The market is primarily dominated by local players such as Health Food Company, Fancl Corporation, and CSPC Pharmaceutical Group. The market for Nutrition and supplements in China is primarily driven by government regulations, increasing customer awareness, and e-commerce platforms. The China nutrition and supplements market in China is segmented by Type, Product, application, and Distribution Channel.
Libya Clinical Diagnostics Market Analysis
This report presents a strategic analysis of the Libya Clinical Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Libya Clinical Diagnostics Market, offering unmatched value, accuracy and expert insights.
Australia Herpes Simplex Virus Therapeutics Market Analysis
Australia Herpes Simplex Virus Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. Herpes simplex virus (HSV) is a common viral infection that can cause a range of diseases in humans. High Prevalence of HSV Infections, Increasing Awareness and Diagnosis, Continued research and development efforts, Technological advancements and Increasing healthcare expenditure, particularly in developed countries, provides a supportive environment for the growth of the HSV Therapeutics market. Social stigma surrounding herpes, Drug-resistant HSV strains provided by limited treatment options are restraining factors in herpes simplex therapeutics market. GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Novartis AG, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd. Are global key players in herpes simplex therapeutics market.
Australia Cardiac Monitoring Devices Market Analysis
This report presents a strategic analysis of the Australia Cardiac Monitoring Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Australia Cardiac Monitoring Devices Market, offering unmatched value, accuracy and expert insights.
South Korea Patient Engagement Solutions Market Analysis
This report presents a strategic analysis of the South Korea Patient Engagement Solutions Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Patient Engagement Solutions Market, offering unmatched value, accuracy and expert insights.
Australia Adrenoleukodystrophy (ALD) Therapeutics Market Analysis
Australia Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Australia Adrenoleukodystrophy (ALD) drugs market.
Australia Batten's Disease (CLN-2) Therapeutics Market Analysis
Australia Batten?s Disease (CLN-2) Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Neuronal Ceroid Lipofuscinosis (NCL), often known as Batten disease, is a rare and severe autosomal recessive neurodegenerative lysosomal storage condition brought on by cellular buildup of aberrant auto-fluorescent lipoproteins (lipofuscin). Seizures and a progressive loss of movement, verbal, visual, and cognitive abilities are features of this neurodegenerative condition that primarily affects the nerve system. Research advancements in nanotechnology could result in the creation of fresh therapies that would benefit persons who suffer from this ailment. Additionally, it is a paediatric brain condition that is extremely rare yet progresses quickly. As a result, Batten's Disease may be exacerbated by the predicted rising prevalence of disease. Therapeutics market (CLN-2). The market for Batten's Disease (CLN-2) Therapeutics is constrained by a lack of treatment and symptoms that are challenging to identify. Regenxbio, Polaryx Therapeutics and Abeona Therapeutics are some of the key players in the market.
Australia Primary Hyperoxaluria (PH) Drugs Market Analysis
Australia Primary Hyperoxaluria (PH) drugs market is expected to grow from $2.1 Mn in 2022 to $8.8 Mn in 2030 with a CAGR of 19% for the year 2022-2030 due to the number of clinical trials including innovative therapeutic assets being investigated at various stages of development has increased in Australia and also new approaches being developed in genetic engineering for the treatment of PH. The market is segmented by type, diagnosis, drug, treatment, and by distribution channel. Some of the key competitors in Australia's primary hyperoxaluria market are Allena Pharmaceuticals, Alnylam Pharmaceuticals, and Amarna Therapeutics.
Australia Primary Hyperoxaluria (PH) Drugs Market Analysis
Australia Primary Hyperoxaluria (PH) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Unmet Medical Need, Increasing Awareness and Diagnosis, Advancements in Research and Development, Growing Investment and Pipeline Development, Collaboration and Patient Advocacy,rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Drugs Market are Allena Pharmaceuticals, Inc., Intellia Drugs, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
Nigeria In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of the Nigeria In Vitro Fertilization (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about Nigeria's In Vitro Fertilization (IVF) Service Market, offering unmatched value, accuracy, and expert insights.
Italy Healthcare Diagnostics Market Analysis
This report presents a strategic analysis of the Italy Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Italy Healthcare Diagnostics Market, offering unmatched value, accuracy and expert insights.
Bulgaria Medical and Diagnostic Laboratory Service Market Analysis
This report presents a strategic analysis of the Bulgaria Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Bulgaria Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy, and expert insights.
